Saadi Ryan H. - 14 Sep 2026 Form 4 Insider Report for Tevogen Inc. (TVGN)

Reporting relationship: Chief Executive Officer, Director, 10%+ Owner
Issuer ticker: TVGN
Reported as of: 14 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Sep 2026, 19:54:35 UTC
Prior SEC filing: 10 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Kirti Desai, Attorney-in-Fact

Key filing fact

Saadi Ryan H. filed Form 4 for Tevogen Inc. (TVGN) on 16 Sep 2026.

Key facts

This page summarizes Saadi Ryan H.'s Form 4 filing for Tevogen Inc. (TVGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Sep 2026, 19:54.

Change

Previous filing in this sequence was filed on 10 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002011728 Primary reporting owner

Saadi Ryan H.

Relationship: Chief Executive Officer, Director, 10%+ Owner
Address: C/O TEVOGEN BIO HOLDINGS INC., 15 INDEPENDENCE BLVD, STE 210, WARREN
Signature: /s/ Kirti Desai, Attorney-in-Fact
Signature date: 16 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TVGN transaction

Common Stock

Award

Transaction value
Shares: +8,000,000
Change %: +216%
Price: $0.000000^*
Shares after: 11,705,689
Date: 14 Sep 2026
Ownership: Direct
Footnotes: F1

TVGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,878
Date: 14 Sep 2026
Ownership: By wife

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of restricted stock under the Tevogen Inc. (the "Company") 2024 Omnibus Incentive Plan, which will vest only upon written certification by the Company's Board of Directors that the Company has achieved $1.0 billion in aggregate revenue during the period from September 14, 2026 through September 30, 2031 (the "Performance Period"). The shares will automatically be forfeited in the event such revenue threshold is not met during Performance Period, upon termination of the Reporting Person's service with the Company for any reason, if it is determined that the Reporting Person has engaged in certain misconduct or competitive activities with the Company, in the event of transfer or attempted transfer prior to vesting, or if the award is not assumed in connection with a change in control.